Podcasts about oncologists

In this episode Dr. Patrick Moore, MD (oncologist and hematologist, Riverside Cancer Institute) explains the difference between oncology and hematology, what common conditions we treat, and why early detection matters. Learn how cancer screening, blood tests (CBC), and routine primary care visits can catch problems early so treatment — from surgery to chemotherapy and targeted therapy — can be most effective. Friendly, clear guidance for patients and families navigating cancer care.

Every year, millions of people's medical care runs into the roadblock known as prior authorization, which requires an insurer to sign off before chemotherapy, surgery or countless other services can proceed. Who does this often onerous process help, who does it hurt and how could it work better for everyone?Guests:Tom Roberts, Oncologist, Mass General Cancer CenterAaron Schwartz, Assistant Professor, Department of Medical Ethics and Health Policy and Department of Medicine, University of PennsylvaniaKathleen, CaregiverLearn more on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Listen in as I talk to Dr. Jeanette LinderWhat happens when a physician stops ignoring her own body and finally begins to listen?Dr. Linder is an Oncologist and Functional & Integrative Medicine physician who transformed her own health after years of exhaustion, overwork, and burnout.Now, she's helping women remove the shame surrounding health, reconnect with their bodies, and build sustainable wellness rooted in grace, healing, and real life.This conversation is powerful, honest, and deeply needed for women who have spent years pouring into everyone else while neglecting themselves.This series was created to bring women together through authentic storytelling because we understand that one woman's testimony can help another woman survive, heal, and thrive. This episode is no exception.Watch by downloading the CTR Media Network App on:Roku • Amazon Fire TV • Android TV • Apple TV • iOS App • Google Play App • Web AppAlso available across social media, podcast streaming platforms, radio, and digital media outlets.The journey share series...conversations that remind us that our stories have power. #JourneyShareSeries #LevelingUpPodcast #AlethiaTucker #MoniquePearson #SoaringWithoutLimits #WomenWhoInspire #WomenEmpoweringWomen #PurposeInMotion #Reinvention #Women40Plus #HealingAndGrowth #WomenInLeadership #AuthenticConversations #CTRMediaNetworkSPONSORS Tandra Price TapIn Magazinehttps://www.tapinmagazine.org/about-tap-in-magazineInstagram: @tapinmazine & Tandra PriceWould you like to be a guest or sponsor? Contact us at: ⁠⁠⁠https://www.levelingupthepodcast.com/shop⁠⁠⁠ Reach Dr. Alethia Tucker by going to: Email: ⁠atucker@joleaseenterprises.com⁠ LinkedIn: ⁠https://www.linkedin.com/in/coachalethiatucker⁠Instagram: ⁠https://www.instagram.com/alethiaatucker⁠ Instagram: ⁠https://www.instagram.com/joleaseenterprises/⁠Facebook: ⁠Alethia Tucker

Smarter treatment paths often begin with asking better questions about what truly works and what simply sounds promising.In this episode, Dr. Stephen Petteruti explains why repurposed drugs are gaining attention in prostate cancer care. He challenges conventional therapies that often offer limited survival benefit despite significant side effects, and highlights how publication bias and interpretation of data can shape treatment narratives. Dr. Stephen outlines how repurposed drugs are selected. Rather than relying on a single solution, he emphasizes synergy: combining therapies like sirolimus and select statins to target cancer pathways while supporting overall health.  If you value longevity and informed decision-making, take a moment to rethink your options. Tune in to the full episode of Repurposed Drugs for Prostate Cancer: What Your Oncologist Will Never Tell You.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Learn more: https://www.drstephenpetteruti.com/ Learn more: https://www.intellectualmedicine.com/ Connect with Dr. Petteruti on:⁠Instagram: ⁠https://www.instagram.com/dr.stephenpetteruti/⁠ Facebook: ⁠https://www.facebook.com/dr.stephenpetteruti⁠ Subscribe to Intellectual Medicine on:Apple Podcast: https://tinyurl.com/DrPetterutiApplePodcast Spotify: https://tinyurl.com/DrPetterutiSpotifyPodcast Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

In this episode, Jeff Malec sits down with Dr. Patrick Welton to trace his remarkable path from Wisconsin kid to Stanford oncologist to veteran futures trader and founder of Welton Investment Partners. Patrick shares how trading pork bellies and interest rate futures in the late 1970s to pay tuition evolved into a decades-long career shaped by mentors at Commodities Corp, relationships with legends like Paul Tudor Jones and John Henry, and a unique “outside inside trader” role that let him keep practicing medicine at Stanford while managing money. He explains how his medical background and scientific training influence his approach to risk, uncertainty, and decision-making, and breaks down Welton's strategy mix across trend following, macro, short-term flow trading, and equity selloff protection. Along the way, Patrick and Jeff dig into the myths around trend following “dying,” why diversification and staying power matter more than narratives, how capital flows really drive short-term moves, and what it takes to survive for 30+ years in a business where most firms disappear. SEND IT!Chapters:00:00-02:03=Intro02:04-09:40=Doctor to Trader: Patrick Welton's Origin Story, From Wauwatosa to Futures and the ER09:41-30:03= From 1987 Crash to Commodities Corp: How Patrick and Annette Turned a Side Hustle into a Trading Career30:04-43:19= Doctors, Scientists, and Traders: Embracing Uncertainty, Reflexivity, and the Real Drivers of Trend Following43:20-56:16= AI, Innovation, and the “CTA Winter”: Cycles, Flows, and the Future of Trend Following56:17-01:14:19= Building Welton's Playbook: Diversifying Alpha, Short-Term Flows, and the Art of Surviving as an Asset Manager01:14:20-01:29:48= Alt Data, Capital Flows, and What Really Matters: Patrick Welton on Research, Edges, and the Future of Trading01:29:49-01:37:47= End-of-Month Myths, Market Microstructure, and the Limits of Short-Term EdgesFrom the Episode: Leverage Is Bad. Except When It Isn't. Morningstar Just Made the Distinction OfficialBook: Richer, Wiser, Happier: How the World's Greatest Investors Win in Markets and Life Book: Market Wizards, Updated: Interviews with Top TradersJack Schwager on The DerivativeFollow along with Dr. Welton and Welton Investment Partners on LinkedIn and be sure to check out Welton's website at welton.com for more information!Don't forget to subscribe to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Derivative⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, follow us on Twitter at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@rcmAlts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠sign-up for our blog digest⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Disclaimer: This podcast is provided for informational purposes only and should not be relied upon as legal, business, or tax advice. All opinions expressed by podcast participants are solely their own opinions and do not necessarily reflect the opinions of RCM Alternatives, their affiliates, or companies featured. Due to industry regulations, participants on this podcast are instructed not to make specific trade recommendations, nor reference past or potential profits. And listeners are reminded that managed futures, commodity trading, and other alternative investments are complex and carry a risk of substantial losses. As such, they are not suitable for all investors. For more information, visit⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.rcmalternatives.com/disclaimer⁠⁠⁠⁠

Dr. Jeanine Cook-Garard talks with Julie Stevens, who at 43 years old, was given a stage 4 colon cancer diagnosis—and only a 14% chance of survival.  She hosts the podcast MOJO Rising... How to Make Cancer Suck Less - and is the author of MOJO Healing... How to Build a Holistic Healing Strategy and Maximize Joy. Julie is also the founder of Vedalife, a health tech startup developing "Ginger," an AI-powered nutrition platform designed to help people optimize their health through comprehensive bio marker tracking and personalized insights.

Macca, Kenny and  Fiona are joined up first this week by Dr. Cameron McLaren, as they discuss evidence based Voluntary Assisted Dying (VAD) in Australia, Dr. Cameron McLaren is a Victorian-based medical oncologist and a leading advocate for, and practitioner of, Voluntary Assisted Dying (VAD) in Australia. He works at Casey Surgical Group (Berwick) and Monash Health, specialising in gastrointestinal, genitourinary, lung, and breast cancers, while supporting patients with end-of-life care options The post Sat, 9th, 2026: Dr. Cameron McLaren, Medical Oncologist, Voluntary Assisted Dying appeared first on Saturday Magazine.

What happens when the world's leading expert on breast cancer becomes the patient? In this episode, we sit down with Dr. Marisa Weiss, renowned oncologist and founder of Breastcancer.org, to discuss her unique 360-degree perspective on the disease. Dr. Weiss shares the raw reality of her own diagnosis and how it shifted her understanding of patient care. We dive deep into the evolving landscape of breast cancer treatment—from targeted therapies to the importance of lifestyle changes—and why "informed decision-making" is the most powerful tool a patient can have.  Dr. Weiss breaks down the "information overload" that often follows a diagnosis and offers a roadmap for navigating treatment with clarity and confidence. We explore the vital importance of listening to your body, asking the "hard" questions to your medical team, and the lifestyle shifts that can impact long-term health. Whether you are currently in treatment, a survivor, or looking to lower your risk, Dr. Weiss provides essential advice on how to be your own best advocate in a complex medical system. Follow Dr. Weiss on Instagram: @drmarisaweiss Follow Breastcancer.org on Instagram: @breastcancerorg Follow us on Instagram: @every.body.talks @jenngiamo @schully Subscribe to our YouTube channel! Don't forget to subscribe to the podcast for free wherever you're listening. Apple Podcasts Spotify Be sure to leave a 5 star rating! It really helps grow the show. If you like the show, telling a friend about it would be amazing!

In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dosing in outpatient settings, and using tocilizumab and IVIG, among other management strategies.  Presenters:  Muhamed Baljevic, MD, FACP Associate Professor of Medicine Division of Hematology-Oncology Department of Medicine Director, Multiple Myeloma Program Director, Vanderbilt Amyloidosis Multidisciplinary Program (VAMP) Co-Chair, Scientific Review Committee, VICC Disease Team Lead, Plasma Cell Dyscrasias and Lymphomas Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center Nashville, Tennessee Jonathan Ticku, MD Medical Oncologist and Hematologist GU Oncology Lead, Mayo Clinic Health System Assistant Professor of Oncology, Mayo Clinic La Crosse, Wisconsin Link to full program: https://bit.ly/4u0xH6q Get access to all of our new podcasts by subscribing to the Decera Clinical Education Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Why are more and more men getting cancer in their 30s?? How can simple pill can treat cancer??? Eating garlic cloves = reduced cancer risk?!We asked an Oncologist our burning questions!!!-Go to www.parkwaycancercentre.com to learn more! Hosted on Acast. See acast.com/privacy for more information.

Yale Cancer Center Director Dr. Eric Winer is interviewed by Dr. Melinda Irwin about becoming on oncologist and the latest advances and challenges in treating cancer. April 26, 2026 Yale Cancer Center Visit: https://medicine.yale.edu/cancer/ Email: canceranswers@yale.edu Call 203-785-4095

I was recently talking to an oncologist about health communication when he mentioned The Pitt, that hit medical drama set in an emergency department in Pittsburgh. Now in its second season, the show prides itself on its accuracy and realism. I’ll share two things this oncologist thinks the show gets right related to communication. Hi, […]

For this week's Ask Me Anything, Professor Janice Walsh, Consultant Oncologist joins Andrea to answer any of your questions!

Dr. Francisco Contreras is the President and Medical Director of the internationally renowned Oasis of Hope Hospital, founded by his father more than 60 years ago. Author of several books. He explains what cancer treatments are gaining results in Mexico but not available in the USA.

Dr. Francisco Contreras is the President and Medical Director of the internationally renowned Oasis of Hope Hospital, founded by his father more than 60 years ago. Author of several books. He explains what cancer treatments are gaining results in Mexico but not available in the USA.

Is it time to rewrite the playbook on oncology?In this episode of Medical Sales U, I sit down with Dr. David Waterhouse, a visionary leader in oncology and community research. From the emotional story that almost kept him out of medicine to the birth of Sarah Cannon (the world's largest community-based research network), this conversation is a masterclass in professional purpose, precision medicine, and the future of patient care.Whether you are a medical student, an aspiring pharma rep, or a healthcare professional, this episode reveals why the "community setting" is the true frontier of medical innovation and how the Hippocratic Oath must evolve in the age of AI.In this episode, we cover:The Personal Journey: Why Dr. Waterhouse tried to avoid oncology—and the mentor who changed his mind.Community Power: The evolution of Sarah Cannon and why 85% of cancer care happens in the community.Precision Medicine 101: How we moved from "untreatable" lung cancer to targeted therapies and biomarkers.The AI Trust Gap: A father and son's perspective on using AI as a partner without losing the human touch.The "Pro" Rep: What doctors actually value in a pharmaceutical partner (it's not a "sale"). CHAPTERS:00:00 - Introduction to Dr. David Waterhouse02:15 - Avoiding Oncology: A Personal Story of Loss05:30 - The Mentor Who Changed Everything09:45 - The Birth of the Sarah Cannon Network13:20 - Why Clinical Trials Belong in the Community18:10 - The Evolution of Lung Cancer Treatment23:50 - Precision Medicine & Biomarkers Explained28:15 - Closing the AI Trust Gap in Medicine34:00 - What Makes a Great Pharma Rep? (The Amgen Story)40:05 - The Hippocratic Oath vs. Fiduciary Duty44:20 - Personal Legacy: Family, Dogs, and SuccessConnect with Us:Follow Dr. David Waterhouse on Linked In: https://www.linkedin.com/in/david-waterhouse-md-mph-fasco-8a14b410/About Medical Sales U:We help high-performers—teachers, nurses, and professionals—break into the medical device and pharmaceutical sales industry through expert coaching and a proven community of winners. We help professionals transition into top-tier medical sales roles: medicalsalesu.com/Share this video with a colleague who needs to hear the truth about "patient-first" leadership.Subscribe for more deep dives into medical sales and healthcare innovation.#Oncology #MedicalSales #PrecisionMedicine #HealthcareInnovation #SarahCannon #ClinicalTrials #AIRules2026 #MedTech

This episode features Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program at City of Hope. Here he shares his thoughts around potentially screening younger patients, due higher rates of colon cancer. He also discusses the importance of educating patients to not overlook potential symptoms, clinical trials, and more.

This episode features Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program at City of Hope. Here he shares his thoughts around potentially screening younger patients, due higher rates of colon cancer. He also discusses the importance of educating patients to not overlook potential symptoms, clinical trials, and more.

Listen to JCO's Art of Oncology article, "The Good Oncologist: Doctoring Lessons from the Art of Oncology" by Zaltz, et al. The article is followed by an interview with Dr Erica Kaye and host Dr. Mikkael Sekeres. Kaye shares how their qualitative analysis of narrative essays authored by cancer care professionals offers insights into what it means to be a "good oncologist." LINK TO FULL TRANSCRIPT

In this episode of the Brown Surgery Podcast, PGY-4 general surgery resident Evan Mitchell sits down with a familiar face: Dr. Josh Cohen. Recently returning to the department as a surgical oncology attending, Dr. Cohen shares his journey from his residency training right here at Brown to his fellowship at Memorial Sloan Kettering, and what it's like starting his new practice.This conversation offers a grounded look into the realities of surgical oncology. Dr. Cohen discusses how to craft a career that balances broad operative skills with specialized cancer care, offering invaluable advice for medical students and residents trying to map out their futures.Key Topics Discussed:Choosing the Specialty: The unique appeal of head-to-toe operations, multidisciplinary care, and integrating complex cases with palliative care.Fellowship Nuances: The distinct differences in training and practice between Surgical Oncology and HPB fellowships.Advice for Trainees: Why you shouldn't stress about specializing too early, and the critical importance of finding a residency that builds a foundation as a strong general surgeon first.A Week in the Life: Managing a schedule dynamically split between the OR, clinic, and dedicated research time.Work-Life Balance & Dispelling Myths: Breaking down the misconception that surgical oncologists must have an intensely rigid personality, and how to maintain healthy boundaries while coordinating complex care across multiple specialties.Guest Bio:Dr. Josh Cohen completed his undergraduate studies at the University of Rochester and medical school at UMass. After completing his general surgery residency at Brown University, he pursued a fellowship at Sloan Kettering before returning to join the Brown surgical faculty.

What if the protein you're working so hard to eat is barely getting absorbed — and the answer has been growing in fresh water for four billion years?This week, I sat down with Catharine Arnston, CEO and Founder of EnergyBits and one of the world's leading experts on algae nutrition, who left a 25-year corporate career after her sister's breast cancer diagnosis sent her down a research rabbit hole she never climbed out of.Here's what blew my mind: when you eat 50 grams of chicken, your body can take two to three days to break it down — and you might only absorb 10% of it as usable amino acids. Five grams of spirulina delivers the equivalent amino acid payload. Instantly. Spirulina isn't even a plant — it's a bacteria with no cell wall, so it absorbs straight through your gums into your bloodstream in seconds.She dropped a bomb about GLP-1s: when you lose fat rapidly, you're not just losing fat — you're releasing the toxins stored inside it directly into your bloodstream. That's exactly when chlorella becomes non-negotiable.And the cancer conversation? Spirulina contains a blue pigment called phycocyanin found nowhere else on Earth. It can identify a cancer cell, strip out the very molecule that lets tumors grow, and trigger apoptosis — cancer cell death — while speeding up energy production in healthy cells. Oncologists are now measuring phycocyanin in blood plasma to track whether cancer is being killed.After hearing this, you'll never look at your protein sources — or your afternoon fatigue — the same way.Episode Links & Resources:Website: https://energybits.com/Use code HYDRATE for 20% offConnect with Tracy:Website: ⁠⁠⁠⁠⁠⁠https://tracyduhs.com/⁠⁠⁠⁠⁠⁠Hydration Shop: ⁠⁠⁠⁠⁠⁠https://sanctuarysd.com/⁠⁠⁠⁠⁠⁠Instagram: ⁠⁠⁠⁠⁠⁠@tracyduhs⁠⁠⁠⁠⁠⁠Flow FAM Community: ⁠⁠⁠⁠⁠⁠https://tracyduhs.com/join-flow-fam/

Philippos A. Costa, MD joins us on OsteoBites to introduce a Phase 2 clinical trial of zanzalintinib for people with osteosarcoma. The study is intended for patients who cannot receive standard chemotherapy or whose cancer has not responded to available treatments. The goal is to explore whether this therapy can control the disease while preserving quality of life during treatment.Philippos A. Costa, MD., is an Oncologist at Yale University. He received his medical degree from the Universiade Federal do Vale do Sao Francisco, Brazil, and completed two internal medicine residencies; at the Universidade Federal de Uberlandia and at the University of Miami Miller School of Medicine, and his fellowship at Yale University. He is an expert in Early Developmental Therapeutics as well as Sarcomas, including osteosarcoma.

Precision oncology promises more data, more insight, and better decisions, yet in practice it often brings more complexity. In a new episode Rafael Rosengarten is joined by Dr. Shakti Ramkissoon, VP of Oncology at Labcorp, to unpack the realities on the ground. From access gaps, reimbursement challenges and fragmented workflows to the promise of longitudinal data and AI-enabled clarity, Dr. Ramkissoon shares how Labcorp is working to simplify complexity while preserving what matters most: human connection in care.⁠⁠⁠⁠TPM E55 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Episode 55 links:Pulse of the Oncologist 2026 reportShakti Ramkissoon on LinkedIn

In this segment of Cancer Registry World, Laurie Kirstein, MD, FACS, a breast surgical oncologist in the Division of Surgical Oncology at Memorial Sloan Kettering Cancer Center and current Chair of the American College of Surgeons Commission on Cancer (CoC), discusses her vision and priorities for the CoC. Drawing on the power of cancer registry data, she highlights the essential role Oncology Data Specialists play in advancing cancer care, quality measurement, and program improvement. Tune in to hear how data-driven insights are shaping the future of oncology.

Welcome to the Oncology Brothers podcast! In this episode, we dived into the evolving treatment algorithms for bladder cancer following the latest data presented at GU ASCO 2026. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Join us as we explore: The role of immunotherapy in non-muscle invasive bladder cancer, highlighting the recent positive trials: CREST with Sasanlimab and POTOMAC with Durvalumab. Insights on the current standard of care and the implications of combining BCG with immunotherapy. The shift in treatment strategies for muscle-invasive bladder cancer, including the new standard of care with the EV-Pembro combination and its impact on pathologic complete response rates. The challenges and considerations in managing side effects associated with new therapies, as well as the importance of patient selection and coordination between urologists and medical oncologists. The emerging role of ctDNA in guiding treatment decisions and the ongoing discussions around the sequencing of therapies in refractory settings. Hope you enjoy this informative discussion that aims to keep you up to date in the world of cancer treatment, here focusing on bladder cancer. Subscribe to our channel for more episodes and discussions on the latest in oncology! #BladderCancer, #NMIBC, #MIBC, #Immunotherapy, #GU26, #OncologyBrothers

Listen to JCO's Art of Oncology article, "The Power of "I Don't Know" by Dr. Sondos Zayed, who is a radiation oncologist at The Ottawa Hospital and an assistant professor at the University of Ottawa, Canada. The article is followed by an interview with Zayed and host Dr. Mikkael Sekeres. Dr Zayed shares a reflection on the unexpected power of saying "I don't know," and how honest uncertainty can deepen trust, guide care and create space for what truly matters in oncology. TRANSCRIPT Narrator: The Power of "I Don't Know", Sondos, Zayed, MD, MPH, FRCPC  Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives and perspectives from authors exploring their experiences in oncology. I'm your host, Mikkael Sekeres. I'm Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami. Joining us today is Dr. Sondos Zayed, a radiation oncologist at the Ottawa Hospital and Assistant Professor at the University of Ottawa, Canada, to discuss her Journal of Clinical Oncology article, "The Power of I Don't Know." At the time of this recording, our guest has no disclosures. She and I have agreed to address each other by first names. Sondos, thank you for contributing to the Journal of Clinical Oncology, and what a pleasure it is to have you join us to discuss your article. Dr. Sondos Zayed: Thank you so much for having me. It's a privilege. Mikkael Sekeres: Can you tell us a little bit about yourself? Where are you from? And walk us through your career up to this point. Dr. Sondos Zayed: Yeah, oh my goodness. So it seems like such a long road and yet so many years left in my career, hopefully. You know, I'm Canadian, and I had the opportunity to grow up in Montreal, which was wonderful, and I went to McGill Medical School, and then after that pursued Radiation Oncology Residency at Western University. And following that I did a fellowship specializing in GI and CNS malignancies with MR-Linac technology in Toronto, and eventually landed in Ottawa, where right now I'm a radiation oncologist treating GI and CNS malignancies and an Assistant Professor at the University of Ottawa. Mikkael Sekeres: That's fantastic. How far are you out of training? Dr. Sondos Zayed: Well, this would be officially my second year essentially as an independent radiation oncologist. Mikkael Sekeres: Wonderful. And I'm curious, what drew you to radiation oncology? Dr. Sondos Zayed: I always say that it was meant to be. And the reason being, when I was in medical school at McGill, they parachuted us out into very niche specialties that we wouldn't otherwise have exposure to. And essentially the way that they would do that is they'd send us an email and say, you know, "Show up at this place, at this location. Here's attached a PowerPoint, just review it before you go." And I get this email and the PowerPoint is talking about, you know, photons and electrons, linear accelerators. And I'm like, "I have no idea what's going on. This is so confusing." I thought I was in medicine. And so I do follow the instructions and I was so lucky that I had such a wonderful supervisor, and he showed me the machines and I saw the coolest cases that day, and it was just such a wonderful experience and the most captivating. And so I just kept on wanting to go back. And the rest is literally history. The really, really fascinating thing about radiation oncology is that it's the mix of physics, it's a mix of like technology, and at the same time there's the medicine and the clinical aspect of it. And there's obviously the privilege to be able to support patients on their most vulnerable journeys with their cancer diagnosis and treatment, et cetera. And so it's a mix of the most interesting things all around and I felt like the best fit for me. Mikkael Sekeres: Well, your passion for it is absolutely palpable. It's really fun to hear the excitement in your voice. Isn't it interesting how one mentor can make the difference in the career path we choose? Dr. Sondos Zayed: Absolutely. Never underestimate the impact they can have on any single trainee at any point in time. It really does turn things around for many people, and it can inspire them to pursue something that they would have never thought of pursuing before. Mikkael Sekeres: I had a very similar experience. It was during fellowship that my very first month of fellowship I was placed on the leukemia service with Rich Stone at Dana-Farber, and I never turned back. He was such a fabulous mentor. I couldn't imagine doing anything else with my career. You write this piece. We loved this piece when you submitted it, myself and the editorial staff. And you write it from the perspective of someone who has recently finished fellowship, which you have. And you write in particular that- this one quote, "During my first year as an attending, I had braced for the steep learning curve, the finality of being the decision maker, the quiet hours at night when treatment decisions still played in my head. What I hadn't prepared for was the weight of uncertainty." It's a great line. So now that you're on the other side of training, what do you think could have prepared you better for the weight of uncertainty? Dr. Sondos Zayed: I had such wonderful mentors throughout my training, and so they were fantastic and I learned so much from them, but sometimes it just took having to be the final decision maker for me not to have to have the security of somebody to just turn back to immediately after a patient encounter, for example, and be like, "Oh, my supervisor can answer this question," or, "Here are my thoughts, but my attending can also join in the discussion," or give their thoughts as well. So that sort of cushion is no longer there. And so when I'm in the room by myself making those decisions with patients, nothing can really prepare you for that. You just have to go in and then do it yourself. Mikkael Sekeres: There is a safety net to training by design and thank God there is, right? Where we can always turn to somebody more experienced than us to answer those hard questions or to know what to do. And that's what's pulled out from under us when we become attendings, when we become the final pathway, when people suddenly turn to us and say, "Okay, what are we going to do here?" or, "What's the answer?" Did anybody during your training model "I don't know"? So did you see your own attendings say "I don't know" to patients and see how that played out? Dr. Sondos Zayed: Not as much, and I think there's a culture in medicine where when people walk into that room, they're hoping that you have all the answers, and you don't want to disappoint them. And so sometimes what we do is we rely on like the evidence and the data and the numbers that are in the literature to answer questions that the patient is asking in an absolute way but we answer it in a probability or a percentage or, "Most likely this will happen," or, "These are the potential, you know, this is the median overall survival," or, "Progression-free survival," or, "This percentage of people have this toxicity," for example. And so it's easy for us to fall back on that cushion of, "These are the numbers and the evidence." And that's what I saw modeled most frequently. But when I started practicing as an attending, what I realized is that when a patient comes in and they sit in front of you, they ask, "How long am I going to live?" What they're asking about is how long they specifically are going to live and not what the median survival in X study is telling us that that's how long they most likely would live, just as an example. And so what I had to do, when I'm speaking to patients, I kind of separate those two concepts where I start with, "I don't know, because I don't have a crystal ball, and your circumstances and how you respond to treatment is something that I can't predict before anything has started. And it's it's just I really don't know. But what I can say is on average in this study, this is what we see, and there's a 95% confidence interval, and most people fall within that." And so I separate their immediate outcome with the data that we have. So that- because sometimes when I say, "Oh, your median survival is one year," they hear, "I'm going to only live for one year." And then you always have these patients that come through and be like, "You know, they told me I only had six months to live, but here I am two years later." And really it is again, we live in a world of probabilities and confidence intervals, but for the patients themselves, this is their life. Mikkael Sekeres: Yeah. One of the aspects of your essay that I really liked is the title, "The Power of 'I Don't Know'" because saying, "I don't know," actually does have some power to it. And I've seen this demonstrated in a couple of different ways. I had a boss once who we'd all be in a meeting, and someone would ask a question, and the boss would say, "I don't know." And he said it in a way where one reaction from other people in the meeting could have been, "Oh, how could he be such an idiot and not know the answer to this?" But what wound up happening is people reacted to it by saying, "Gee, if he doesn't know, then it's okay that I don't know also. And maybe if he doesn't know, that means that maybe I thought I knew, but maybe I really don't know as well as I should." And it makes you kind of redouble your efforts to understand whatever's being communicated in the meeting. So I always thought that there was this power in saying, "I don't know," in meetings, but you bring up the power of "I don't know" in patient interactions. So tell me what is the power in saying, "I don't know," to a patient? What is it that that conveys to a patient and how does that affect the relationship that you have with your patients? Dr. Sondos Zayed: The way that I have learned to see it over the last year and a bit is that when I say, "I don't know," what they hear is honesty, and they hear that, you know, I'm not going to pretend to make up a number or make up an outcome when I'm not sure of it. And they hear that physicians are also very human. And it makes us seem much more approachable. And so what I noticed started happening when I admitted there were things that I don't know where sometimes there was no way of me knowing answers to some of their questions is they started seeing the human aspect of what we do every day. And then they started wanting to share more of their human experience and what really matters to them the most. So they started sharing, "Okay, well, if if the physician doesn't know, these are the things that are important to me. I want to be able to walk my daughter down the aisle in a few months. I want to be able to play with my grandchildren. I want to be able to be at home when the end comes." So it opened this discussion where my admitting that I don't know is a form of vulnerability, and I say that, and that allowed them to be a bit more vulnerable with what it is that they really wanted to achieve in the time that they had left. And it closed gaps where the physician is seen as not somebody who necessarily has all the answers, but somebody who when they don't know, they will tell us, and what they can tell us in terms of what they can offer for treatment, what possible outcomes are, what they can expect, all these things that they do know, they will tailor to what it is that is important to them. I felt like it was more of a bridge than it was scarier. It built bonds and it built bridges as opposed to them feeling that they're not being cared for. Mikkael Sekeres: Sounds like it establishes an environment of honesty and that leads to trust in the relationship between you and your patients. Dr. Sondos Zayed: Yeah, I would agree. Mikkael Sekeres: When people ask, "How long do I have to live?" it also, what I've learned from communications experts in oncology is that it gives us an opportunity to say, "Why do you ask?" And that can lead to a discussion of goals and what are we working toward here and make sure that we're on the same page with what our patients' expectations are as well. Dr. Sondos Zayed: Absolutely. Mikkael Sekeres: You talk about vulnerability with your patients. I wonder if you could talk a little bit about our roles as doctors and nurses and pharmacists, when is it expected that we provide a concrete answer and when is it okay to be vulnerable and say, "I don't know"? Dr. Sondos Zayed: That really depends on the situation. So I feel like when we should be able to provide concrete answers when we have the evidence and information to be able to answer them in a way that the patient requires. When we don't have that evidence and we don't have that clear picture of, "Oh, this is obviously the answer," based on our usually at least decade plus of training, then being able to admit, "I don't know," actually opens the doors for discussion, anchor that "I don't know" into something more concrete. So when you say, "I don't know," you don't kind of leave it in the air, that can certainly be cause for anxiety. But sort of taking that, "I don't know," and then framing the subsequent part of that conversation about what are the things that you do know about the question that they asked and how you can support them by giving them the information that you are confident about. Mikkael Sekeres: Has it ever backfired on you? Dr. Sondos Zayed: Not yet, but I've got many years of practice to come. Mikkael Sekeres: It has on me. I don't know that I would say maybe "backfired" is too strong, but there are times when I've said, "I don't know," and my patients have said, "But you're the doctor. You're supposed to know." Dr. Sondos Zayed: Mm-hm. Mikkael Sekeres: And I found that creates an opportunity to talk about expectations and where the limits of our knowledge are and where we can provide estimates and ranges, but can't give people a precise answer. Dr. Sondos Zayed: Mm-hm. Mikkael Sekeres: In your essay, you write, "When the reality doesn't match the implied promise, patients don't lose faith in the data, they lose faith in the person who gave it. That is how trust erodes." I thought that was just very elegantly phrased. Has that ever happened to you where you've provided an estimate maybe of a potential outcome and things didn't work out that way for the patient? Dr. Sondos Zayed: Yes, that has, and I think most physicians can sort of share that experience, to be honest, where it'll come back and say, "Well, actually I didn't I didn't have that side effect," or, "Actually I lived longer than you'd anticipated," for example, or like, "It didn't have that outcome." And I think that's where the idea of saying, "I don't know," actually came from, where I I realized that a lot of the times when we turn back to the data, patients hear it as like, "Oh, this is the concrete truth of what exactly is going to happen to me." But to sort of distinguish between, "Oh, this is what we see in the data versus what exactly is going to happen to you," making that distinction is what by saying, "I don't know," is what has helped me try to prevent these outcomes from happening, or prevent the erosion of of trust by sounding maybe overconfident with specific things that mean so much to them. So- and this is their life, right? They come in and they hear these things and they remember them forever. And we see so many people on a daily basis and sometimes we don't keep track of every single word we've ever said. And so- but these words have so much weight to them. And so distinguishing between what we see in and saying, "I don't know," and then, "Here's what I do know," and saying that for them specifically, it's almost impossible to predict, it really helps prevent, in my opinion, the erosion of of that trust so that you don't have somebody saying, "Oh, actually you were wrong afterwards," or misunderstanding or misinterpreting what is that we're trying to convey by giving that information. Mikkael Sekeres: And that's a great place to end a great discussion and a wonderful piece. It has been such a pleasure to have Dr. Sondos Zayed, who is a radiation oncologist at the Ottawa Hospital and Assistant Professor at the University of Ottawa, Canada, to discuss her essay, "The Power of 'I Don't Know.'" Sondos, thank you so very much for submitting your article and for joining us today. Dr. Sondos Zayed: Thank you so much. Mikkael Sekeres: If you've enjoyed this episode, consider sharing it with a friend or colleague, or leave us a review. Your feedback and support helps us continue to have these important conversations. If you're looking for more episodes, follow our show on Apple, Spotify, or wherever you listen, and explore more from ASCO at ASCO.org/podcasts. Until next time, this has been Mikkael Sekeres for JCO Cancer Stories: The Art of Oncology. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Show notes:Like, share and subscribe so you never miss an episode and leave a rating or review. Guest Bio: Dr Sondos Zayed is a Radiation Oncologist at The Ottawa Hospital and Assistant Professor at the University of Ottawa, Canada.

In today's episode, we sat down with Kelly E. McCann, MD, PhD, and Sara Nunnery, MD, MSCI, as they shared their stories and perspectives as leading women in oncology in honor of International Women's Day, which is observed annually on March 8. Dr McCann is a breast medical oncologist in the University of California system. Dr Nunnery is a breast medical oncologist with Tennessee Oncology in Nashville.Forming the backdrop of our exclusive discussion were insights shared during the 2026 OncLive Women in Oncology event, which took place on March 5, 2026, to kick off the 43rd Annual Miami Breast Cancer Conference. In our exclusive interview, Drs McCann and Nunnery used the Women in Oncology discussion as the basis for relaying their own experiences, observations, and advice regarding setting boundaries, striving for work-life harmony, advocating for oneself, and more.

Cancer, Character, and Calling: The Oncologist's Journey, hosted by Girindra Raval, MD, is a podcast highlighting how top oncologists have navigated the field over the course of their careers, the passion that drove them to enter the oncology space, and the ongoing work that will continue to transform cancer care. Each episode, Raval will sit down with a top oncologist to dive into their background, highlight their career achievements, discuss key issues still being addressed in their field, and explore their interests outside of the clinic and lab.In this episode, Raval welcomed Hossein Borghaei, DO, MS, who is the chief of the Division of Thoracic Medical Oncology, the codirector of the Immune Monitoring Facility, the Gloria and Edmund M. Dunn Chair in Thoracic Oncology, and a professor in the Department of Hematology/Oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania. Their conversation focused on Borghaei's personal journey into medicine and oncology, highlighting how immigration, mentorship, and scientific curiosity shaped his career and philosophy of patient care.Reflecting on his career, Borghaei described major advances in the field of lung cancer treatment, including targeted therapies and immunotherapy, which he witnessed firsthand. He emphasized that clinical observation and collaboration have driven progress in this area of oncology and will continue to do so. He believes immunotherapy still holds untapped potential and that future breakthroughs will come through continued scientific cooperation.Borghaei advised trainees to persist throughout their careers despite rejection, seek mentorship, and remain committed to improvement. He views artificial intelligence as a powerful tool for research and diagnostics but not a replacement for physicians, emphasizing the irreplaceable value of human connection in patient care. Throughout the interview, he stressed optimism, compassion, and lifelong learning as essential qualities for oncologists, highlighting the profound relationships formed with patients even in the most difficult moments.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

Dr. Sue Hwang, author of, From Both Sides of the Curtain: Lessons and Reflections from an Oncologist's Breast Cancer Journey discusses the complex, frequently changing emotional landscape that every cancer patient faces.

“When Jesus heard it, He said to them, ‘Those who are well have no need of a physician, but those who are sick. I did not come to call the righteous, but sinners, to repentance.’” (Mark 2:17 NKJV) Jesus interacted with a remarkably diverse group of people during His public ministry. The Gospels record His encounters with Pharisees, tax collectors, Roman officials, fishermen, a Samaritan woman, and a host of others. One of the extraordinary things about these encounters is the personalized attention He gave each person, whether He was offering encouragement, rebuke, or healing. He recognized that every man, every woman, and every child is different. And though they have many of the same problems and the same basic needs, He realized that there were unique things about them that required individual ministry. He saw people for exactly who they were. He understood exactly what they needed. And He provided it. It’s no wonder people refer to Him as the Great Physician. Jesus Himself said, “Those who are well have no need of a physician, but those who are sick. I did not come to call the righteous, but sinners, to repentance” (Mark 2:17 NKJV). Like a physician, Jesus usually saw people at their worst. I’ve always thought that one of the hardest things about being a doctor is that you only see people when they’re sick or in need of medical assistance. Most physicians don’t get a lot of patients stopping by their office to say, “Hey, Doc, I’m feeling great! I just wanted to let you know. Want to go to lunch?” You don’t usually call your doctor when you’re feeling good. You call when you’re feeling sick. And your doctor will have you come in, examine you, and apply the necessary treatment to the area of need. Doctors, of course, are limited in their areas of expertise. Cardiologists specialize in heart health. Dermatologists specialize in matters of the skin. Gastroenterologists specialize in digestive system health. Hematologists specialize in blood disorders. Oncologists specialize in cancer treatment. The list goes on and on. Jesus, on the other hand, can treat the whole person. He caused the blind to see, the deaf to hear, the disabled to walk, and the dead to live. He removed the spiritual torment of the demon-possessed. He eased the emotional struggles of the frightened and grieving. He didn’t just improve people’s quality of life; He gave them a life they never knew was possible. That’s what He meant when He said, “I have come that they may have life, and that they may have it more abundantly” (John 10:10 NKJV). Jesus still provides personalized care for His people. He knows what you need. In fact, He knows better than you do what you need. And He can and will provide it. Reach out to Him. Open yourself to His loving ministry. Let Him guide you into the life He has planned for you. Enjoy all the benefits of having a personal Physician. Reflection question: How has Jesus impacted your life in a personal way? Discuss Today's Devo in Harvest Discipleship! — The audio production of the podcast "Greg Laurie: Daily Devotions" utilizes Generative AI technology. This allows us to deliver consistent, high-quality content while preserving Harvest's mission to "know God and make Him known." All devotional content is written and owned by Pastor Greg Laurie. Listen to the Greg Laurie Podcast Become a Harvest PartnerSupport the show: https://harvest.org/supportSee omnystudio.com/listener for privacy information.

Near-Death Experience Expert Dr. Jeffrey Long.  This Past Weekend w/ Theo Von. ACU Saturday Series.  Watch this video at- https://youtu.be/RfOGrMfcMPg?si=TO91iinJ8GHL59J6 Theo Von 4.4M subscribers 2,715,431 views Jan 23, 2024 This Past Weekend w/ Theo Von Dr. Jeffrey Long is a physician, author and researcher of near-death experiences. His book “Evidence of the Afterlife: The Science of Near-Death Experiences” is a New York Times Best-Seller that compiles research from more than 1,600 cases and interviews. Outside of his research he is a practicing Oncologist in Kentucky. Dr. Jeffrey Long joins Theo to talk about the phenomena of near-death experiences, what's really going on in our minds when we come close to the end, what people claim to see in their visions, why he believes there's an afterlife based on his research, and what we can learn from these experiences to get the most out of life. Dr. Jeffrey Long's book “Evidence of the Afterlife”: https://amzn.to/3OaVZHO Near-Death Experience Research Foundation: https://nderf.org/ ------------------------------------------------ Tour Dates! https://theovon.com/tour New Merch: https://www.theovonstore.com   --------------------------------------------------------------------  Check out our ACU Patreon page: https://www.patreon.com/ACUPodcast   HELP ACU SPREAD THE WORD!  Please go to Apple Podcasts and give ACU a 5 star rating. Apple canceled us and now we are clawing our way back to the top. Don't let the Leftist win. Do it now! Thanks. Also Rate us on any platform you follow us on. It helps a lot. Forward this show to friends. Ways to subscribe to the American Conservative University Podcast Click here to subscribe via Apple Podcasts Click here to subscribe via RSS You can also subscribe via Stitcher FM Player Podcast Addict Tune-in Podcasts Pandora Look us up on Amazon Prime …And Many Other Podcast Aggregators and sites ACU on Twitter- https://twitter.com/AmerConU . Warning- Explicit and Violent video content.   Please help ACU by submitting your Show ideas. Email us at americanconservativeuniversity@americanconservativeuniversity.com   Endorsed Charities -------------------------------------------------------- Pre-Born! Saving babies and Souls. https://preborn.org/ OUR MISSION To glorify Jesus Christ by leading and equipping pregnancy clinics to save more babies and souls. WHAT WE DO Pre-Born! partners with life-affirming pregnancy clinics all across the nation. We are designed to strategically impact the abortion industry through the following initiatives:… -------------------------------------------------------- Help CSI Stamp Out Slavery In Sudan Join us in our effort to free over 350 slaves. Listeners to the Eric Metaxas Show will remember our annual effort to free Christians who have been enslaved for simply acknowledging Jesus Christ as their Savior. As we celebrate the birth of Christ this Christmas, join us in giving new life to brothers and sisters in Sudan who have enslaved as a result of their faith. https://csi-usa.org/metaxas   https://csi-usa.org/slavery/   Typical Aid for the Enslaved A ration of sorghum, a local nutrient-rich staple food A dairy goat A “Sack of Hope,” a survival kit containing essential items such as tarp for shelter, a cooking pan, a water canister, a mosquito net, a blanket, a handheld sickle, and fishing hooks. Release celebrations include prayer and gathering for a meal, and medical care for those in need. The CSI team provides comfort, encouragement, and a shoulder to lean on while they tell their stories and begin their new lives. Thank you for your compassion  Giving the Gift of Freedom and Hope to the Enslaved South Sudanese -------------------------------------------------------- Food For the Poor https://foodforthepoor.org/ Help us serve the poorest of the poor Food For The Poor began in 1982 in Jamaica. Today, our interdenominational Christian ministry serves the poor in primarily 17 countries throughout the Caribbean and Latin America. Thanks to our faithful donors, we are able to provide food, housing, healthcare, education, fresh water, emergency relief, micro-enterprise solutions and much more. We are proud to have fed millions of people and provided more than 15.7 billion dollars in aid. Our faith inspires us to be an organization built on compassion, and motivated by love. Our mission is to bring relief to the poorest of the poor in the countries where we serve. We strive to reflect God's unconditional love. It's a sacrificial love that embraces all people regardless of race or religion. We believe that we can show His love by serving the “least of these” on this earth as Christ challenged us to do in Matthew 25. We pray that by God's grace, and with your support, we can continue to bring relief to the suffering and hope to the hopeless.   Report on Food For the Poor by Charity Navigator https://www.charitynavigator.org/ein/592174510   -------------------------------------------------------- Disclaimer from ACU. We try to bring to our students and alumni the World's best Conservative thinkers. All views expressed belong solely to the author and not necessarily to ACU. In all issues and relations, we hope to follow the admonitions of Jesus Christ. While striving to expose, warn and contend with evil, we extend the love of God to all of his children. ---------------------------------------------------------------------------